Search

everythinglearnresearchcommunity

for

Search:↓

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Genetic testing confirmed a young girl has Atrichia with Papular Lesions due to mutations in the hairless gene.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Low dose methotrexate does not increase hair fall and may reduce it.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

All four treatments for early rheumatoid arthritis had similar safety profiles.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Adalimumab can cause complete hair loss in rare cases.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Methotrexate plus prednisolone had the fewest serious side effects.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Long-term glucocorticoid use can cause skin problems like easy bruising and poor wound healing, especially at higher doses.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

The convention highlighted knowledge sharing, networking, and the importance of active participation in dermatology.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

New military hair rules for women promote inclusivity and prevent hair damage.

Eating the right nutrients can improve hair health, but taking extra supplements usually doesn't help unless you have a deficiency.

Different types of hair loss in lupus need careful diagnosis for proper treatment.